The findings were confirmed in a tissue-specific analysis integrating breast and liver cancer mutations with CTCF binding sites of the cancer cell lines MCF-7 and HepG2, respectively (Additional file 1: Figure S4B, S4C). The gene discussed is CTCF; the disease is cancer.